CIK: 0001687078
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics INC | Stock-Other | 33.48% | -0.67% | — | |
| 2 | 2662247D | Iteos Therapeutics INC | Stock-Other | 9.85% | — | -0.72% | |
| 3 | TCRRUSD | Tcr2 Therapeutics INC | Stock-Other | 9.09% | — | — | |
| 4 | RPTX | Repare Therapeutics INC | Stock-Other | 8.59% | — | -19.02% | |
| 5 | ✓ | Stock-Other | 7.28% | — | -18.00% | ||
| 6 | HOWL | Werewolf Therapeutics INC | Stock-Other | 6.84% | -0.02% | — | |
| 7 | ✓ | Oncorus INC | Stock-Other | 5.39% | — | — | |
| 8 | ✓ | MEI Pharma, Inc. | Stock-Other | 4.75% | — | — | |
| 9 | TPB | Turning Point Brands, Inc. | Stock-Other | 3.45% | — | — | |
| 10 | EPZMEUR | Epizyme INC | Stock-Other | 3.18% | — | — | |
| 11 | GTHXEUR | G1 Therapeutics INC | Stock-Other | 2.93% | — | -12.39% | |
| 12 | ✓ | Merus N V | Stock-Other | 2.43% | — | — | |
| 13 | YMABUSD | Y-mabs Therapeutics INC | Stock-Other | 1.87% | — | — | |
| 14 | ✓ | Adc Therapeutics SA | Stock-Other | 0.87% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics INC | — | EXIT | Sold out |
| 2 | ✓ | — | EXIT | Sold out | |
| 3 | 2662247D | Iteos Therapeutics INC | — | EXIT | Sold out |
| 4 | TCRRUSD | Tcr2 Therapeutics INC | — | EXIT | Sold out |
| 5 | RPTX | Repare Therapeutics INC | — | EXIT | Sold out |
| 6 | ✓ | MEI Pharma, Inc. | — | EXIT | Sold out |
| 7 | ✓ | Oncorus INC | — | EXIT | Sold out |
| 8 | TPB | Turning Point Brands, Inc. | — | EXIT | Sold out |
| 9 | GTHXEUR | G1 Therapeutics INC | — | EXIT | Sold out |
| 10 | EPZMEUR | Epizyme INC | — | EXIT | Sold out |
| 11 | ✓ | Merus N V | — | EXIT | Sold out |
| 12 | YMABUSD | Y-mabs Therapeutics INC | — | EXIT | Sold out |
| 13 | ✓ | Adc Therapeutics SA | — | EXIT | Sold out |